Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening

Recruiting

18 years - 99 years

All

2000 participants needed

1 Location

Brief description of study

This study seeks to find out whether an oral medication called Fenofibrate can slow or prevent worsening of diabetic retinopathy.

Detailed description of study

This study seeks to find out whether an oral medication called Fenofibrate can slow or prevent worsening of diabetic retinopathy.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Diabetes, Diabetic Retinopathy
Age: 18 years - 99 years
Gender: All

Ages 18+ Diagnosed with Diabetic Retinopathy

Updated on 04 Aug 2024. Study ID: 845026

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).